July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Philippe Aftimos Highlights ASCO 2025 Presentation by Elisa Agostinetto on SYNERGY Phase 2 Trial in Metastatic TNBC
Jun 3, 2025, 18:29

Philippe Aftimos Highlights ASCO 2025 Presentation by Elisa Agostinetto on SYNERGY Phase 2 Trial in Metastatic TNBC

Philippe Aftimos, Medical Oncologist at the Jules Bordet Institute, shared a post on LinkedIn:

“At the metastatic breast cancer poster session this morning at ASCO25, Elisa Agostinetto presents OS results and ctDNA analyses from the SYNERGY randomized phase 2 academic study sponsored by Institut Jules Bordet.
SYNERGY investigated the combination of oleclumab and durvalumab with chemotherapy in the 1st line setting of metastatic TNBC.”

Read OncoDaily’s Special Articles about ASCO 2025:

Highlights from ASCO 2025 Day 1

Highlights from ASCO 2025 Day 2

Highlights from ASCO 2025 Day 3

Highlights from ASCO 2025 Day 4

Elisa Agostinetto